Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.130
Buy
RSI(14)
62.300
Neutral
STOCH(KDJ)(9,3,3)
82.714
Neutral
ATR(14)
0.526
Low Volatility
CCI(14)
104.390
Buy
Williams %R
6.389
Overbought
TRIX(12,20)
0.300
Sell
StochRSI(14)
70.805
Buy
Search
Viatris Inc
VTRSAdd to Watchlist
17.635USD
+0.395+2.29%
Close 07-27 16:00（ET）Quotes delayed by 15 min
20.30BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+2.29%
5 Days
+3.80%
1 Month
+7.99%
6 Months
+34.41%
Year to Date
+41.65%
1 Year
+87.41%
Key Figures
17.330Open
17.750High
9.76MVolume
LossP/E TTM
6.62P/E Dynamic
0.480Dividend TTM
0.85%Turnover Ratio
17.240Prev. Close
17.280Low
125.44MTurnover
LossP/E Static
1.38P/B
2.72%Div Yield TTM
-0.79%ROA
17.53052wk High
1.05Volume Ratio
-634.20MNet Profit
1.15BShares
-0.2986EPS TTM
0.89Beta
-1.96%ROE
8.40052wk Low
2.73%Amplitude
39.18%Gross Margin
20.30BMarket Cap
3.02Reward/Risk
1.84%Risk Rate
TradingKey Stock Score of Viatris Inc
Currency: USD Updated: 2026-07-27Key Insights
Viatris Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 30 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 17.59.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Viatris Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Viatris Inc Highlights
StrengthsRisks
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. It produces oral solid doses, injectables, and products with complex dosage forms.
Undervalued
The company’s latest PE is -59.07, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.01B shares, decreasing 6.51% quarter-over-quarter.
Held by Francisco Garcia Parames
Star Investor Francisco Garcia Parames holds 4.71M shares of this stock.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
17.589
Target Price
+2.02%
Upside Space
Viatris Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
11
analysts
Buy
Current Rating
17.589
Target Price
+2.02%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Viatris Inc
VTRS
11
Biogen Inc
BIIB
38
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Indicators
Moving Average
Indicators
Value
Direction
MA5
17.351
Buy
MA10
17.135
Buy
MA20
16.788
Buy
MA50
16.385
Buy
MA100
15.383
Buy
MA200
13.791
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Viatris Inc Info
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. It produces oral solid doses, injectables, and products with complex dosage forms.
Ticker SymbolVTRS
CompanyViatris Inc
CEOSmith (Scott A)
Websitehttps://www.viatris.com/en
Shareholders
Related Instruments
+0.16%
+0.98%
+0.25%
-0.96%
-0.23%
+0.70%
+0.06%
+1.88%
+0.92%
+0.49%
+0.76%
+0.34%
+1.52%
+1.21%
+1.18%
0.00%
+1.72%
-3.24%
+1.16%
+0.57%Popular Instruments
52330.700
+91.700 (+0.18%)
27850.300
-205.700 (-0.73%)
7409.300
-9.100 (-0.12%)
14737.000
-376.000 (-2.49%)
62541.000
-1264.000 (-1.98%)
6302.300
-9.000 (-0.14%)
80.150
-1.187 (-1.46%)
336.900
+3.880 (+1.17%)
196.560
-10.280 (-4.97%)
4043.400
-33.040 (-0.81%)
FAQs
What is the current price of Viatris Inc (VTRS)?
The current price of Viatris Inc (VTRS) is 17.64.
What is the symbol of Viatris Inc?
The ticker symbol of Viatris Inc is VTRS.
What is the 52-week high of Viatris Inc?
The 52-week high of Viatris Inc is 17.53.
What is the 52-week low of Viatris Inc?
The 52-week low of Viatris Inc is 8.40.
What is the market capitalization of Viatris Inc?
The market capitalization of Viatris Inc is 20.30B.
Is Viatris Inc (VTRS) currently rated as Buy, Hold, or Sell?
According to analysts, Viatris Inc (VTRS) has an overall rating of Buy, with a price target of 17.59.
What is the Earnings Per Share (EPS TTM) of Viatris Inc (VTRS)?
The Earnings Per Share (EPS TTM) of Viatris Inc (VTRS) is -3.00.